FR2573307B1 - Implants anabolisants a liberation prolongee - Google Patents

Implants anabolisants a liberation prolongee

Info

Publication number
FR2573307B1
FR2573307B1 FR8418230A FR8418230A FR2573307B1 FR 2573307 B1 FR2573307 B1 FR 2573307B1 FR 8418230 A FR8418230 A FR 8418230A FR 8418230 A FR8418230 A FR 8418230A FR 2573307 B1 FR2573307 B1 FR 2573307B1
Authority
FR
France
Prior art keywords
anabolizing
implants
extended release
extended
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8418230A
Other languages
English (en)
French (fr)
Other versions
FR2573307A1 (fr
Inventor
Jacques Alexandre Cuvelier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRB Virbac SA
Original Assignee
CRB Virbac SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRB Virbac SA filed Critical CRB Virbac SA
Priority to FR8418230A priority Critical patent/FR2573307B1/fr
Priority to ZA858486A priority patent/ZA858486B/xx
Priority to DE19853539408 priority patent/DE3539408A1/de
Priority to BE1/011375A priority patent/BE903610A/fr
Priority to GB08527915A priority patent/GB2167662B/en
Priority to NZ214179A priority patent/NZ214179A/xx
Priority to IT22829/85A priority patent/IT1188195B/it
Priority to AU49982/85A priority patent/AU585280B2/en
Priority to NL8503227A priority patent/NL8503227A/nl
Publication of FR2573307A1 publication Critical patent/FR2573307A1/fr
Application granted granted Critical
Publication of FR2573307B1 publication Critical patent/FR2573307B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8418230A 1984-11-22 1984-11-22 Implants anabolisants a liberation prolongee Expired FR2573307B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8418230A FR2573307B1 (fr) 1984-11-22 1984-11-22 Implants anabolisants a liberation prolongee
ZA858486A ZA858486B (en) 1984-11-22 1985-11-05 Sustained-release anabolic implants
DE19853539408 DE3539408A1 (de) 1984-11-22 1985-11-07 Vorrichtungen, die anabolisierende implantate mit verlaengerter freisetzung enthalten
BE1/011375A BE903610A (fr) 1984-11-22 1985-11-08 Dispositifs contenant des implants anabolisants a liberation prolongee
GB08527915A GB2167662B (en) 1984-11-22 1985-11-12 Sustained-release anabolic implants
NZ214179A NZ214179A (en) 1984-11-22 1985-11-13 Sustained-release device with solid matrix based on hydrophobic insoluble polymers
IT22829/85A IT1188195B (it) 1984-11-22 1985-11-14 Dispositivi contenenti degli impianti anabolizzanti a liberazione prolungata
AU49982/85A AU585280B2 (en) 1984-11-22 1985-11-18 Sustained-release anabolic implants
NL8503227A NL8503227A (nl) 1984-11-22 1985-11-22 Inrichtingen met anaboliserende inplantaten met een langdurige afgifte.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8418230A FR2573307B1 (fr) 1984-11-22 1984-11-22 Implants anabolisants a liberation prolongee

Publications (2)

Publication Number Publication Date
FR2573307A1 FR2573307A1 (fr) 1986-05-23
FR2573307B1 true FR2573307B1 (fr) 1988-06-10

Family

ID=9310081

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8418230A Expired FR2573307B1 (fr) 1984-11-22 1984-11-22 Implants anabolisants a liberation prolongee

Country Status (9)

Country Link
AU (1) AU585280B2 (de)
BE (1) BE903610A (de)
DE (1) DE3539408A1 (de)
FR (1) FR2573307B1 (de)
GB (1) GB2167662B (de)
IT (1) IT1188195B (de)
NL (1) NL8503227A (de)
NZ (1) NZ214179A (de)
ZA (1) ZA858486B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003440A1 (en) * 1984-01-31 1985-08-15 International Foundation For Biochemical Endocrino Method for promoting growth and improved meat quality in meat-producing animals with female steroidal hormones
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US5601835A (en) * 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
CA2336879C (en) * 1998-07-20 2010-06-01 Peptech Limited Sustained-release formulations comprising peptides, polypeptides, proteins or nucleic acids as active ingredients
US7767708B2 (en) 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
BR9914996A (pt) * 1998-11-04 2001-07-10 Schering Corp Composições estimulantes de crescimento melhorado
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
JP5184727B2 (ja) 1999-06-11 2013-04-17 ワトソン ファーマシューティカルズ， インコーポレイテッド 女性への非経口アンドロゲンステロイドの投与
AU1756001A (en) * 1999-12-16 2001-06-25 Pharmacia & Upjohn Company Implant composition containing melengestrol acetate and trenbolone acetate
BR0207052A (pt) * 2002-10-15 2004-08-10 Natura Cosmeticos Sa Composição cosmética sólida
US20100144687A1 (en) 2008-12-05 2010-06-10 Glaser Rebecca L Pharmaceutical compositions containing testosterone and an aromatase inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB215137A (en) * 1923-02-23 1924-05-08 Frank Leslie Gridner Improvements in and relating to adjustable chairs
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
US3920806A (en) * 1973-05-04 1975-11-18 Merck & Co Inc Growth promoting subcutaneous compositions
FR2239988A1 (en) * 1973-08-08 1975-03-07 Aries Robert Animal hormone implants - comprising a mixt. of hormone and fatty acid ester of hormone
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4333919A (en) * 1979-09-12 1982-06-08 Eli Lilly And Company Growth promotant controlled release formulations and method of treatment
US4331652A (en) * 1979-09-12 1982-05-25 Eli Lilly And Company Controlled release parasitic formulations and method

Also Published As

Publication number Publication date
DE3539408A1 (de) 1986-06-05
GB2167662A (en) 1986-06-04
GB2167662B (en) 1988-11-30
AU4998285A (en) 1986-05-29
AU585280B2 (en) 1989-06-15
FR2573307A1 (fr) 1986-05-23
GB8527915D0 (en) 1985-12-18
NZ214179A (en) 1989-06-28
IT8522829A0 (it) 1985-11-14
BE903610A (fr) 1986-05-09
ZA858486B (en) 1986-06-25
NL8503227A (nl) 1986-06-16
IT1188195B (it) 1988-01-07

Similar Documents

Publication Publication Date Title
PT80564B (pt) Dispositivos de libertacao
DK32285A (da) Et dieselaggregat
DK426088A (da) Automatisk selvbetjent afregningsanlaeg
FR2573307B1 (fr) Implants anabolisants a liberation prolongee
DK185889A (da) Automatisk spraydaase
AT380780B (de) Implantat
FR2617040B1 (fr) Prothese cotyloidienne
FR2605793B1 (fr) Traversees a liberation des contraintes
DK56486A (da) Laarbensimplantat
FR2611486B1 (fr) Prothese uretrale
DK1386D0 (da) Lokkemiddelsafgivende fiskemadding
AT387258B (de) Fallbremse
BR8506438A (pt) Aperfeicoamentos relacionados a pesticidas
FR2629338B1 (fr) Implant femoro-rotulien
BR8702236A (pt) Servoatuador de auxilio a frenagem
NO167254C (no) Plaster
FR2621211B1 (fr) Germoir a graines
KR850005729U (ko) 자동 등밀이기
FR2628315B1 (fr) Implant cotyloidien
FI840128A0 (fi) Tillsatsanordning foer en med en skopa foersedd graevanordning foer tjaelbrytning
KR890018791U (ko) 자동 등밀이기
IT1224155B (it) Irdomo piramidale
IT8314512V0 (it) Ancora a disincaglio obbligato
RO96733A3 (ro) Agregat de tencuit
BR1101135A (pt) Um composto

Legal Events

Date Code Title Description
ST Notification of lapse